09.10.2023 - IGEA Pharma N.V. / Key word(s): Letter of Intent/Letter of Intent IGEA Pharma N.V.: IGEA to update on RBCARE business combination 09-Oct-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible . Seite 1
30.09.2023 - IGEA Pharma N.V. / Key word(s): Half Year Results/Half Year Results IGEA Pharma N.V.: IGEA discloses its half-year figures 2023 30-Sep-2023 / 19:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible . Seite 1
30.05.2023 - IGEA Pharma N.V. / Key word(s): Miscellaneous IGEA Pharma N.V.: IGEA to update on strategic refocusing decisions. 30-May-2023 / 01:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content . Seite 1
15.05.2023 - IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters 15-May-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is . Seite 1
01.05.2023 - IGEA Pharma N.V. / Key word(s): Annual Results/Annual Results IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure 01-May-2023 / 23:46 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely . Seite 1